טוען...
An albumin-based tumor-targeted oxaliplatin prodrug with distinctly improved anticancer activity in vivo
The design of targeted platinum(iv) prodrugs is a very promising approach to enhance the low selectivity of platinum(ii) drugs towards cancerous tissue in order to reduce the impact on healthy tissue and, consequently, the often severe side-effects. Herein, we report a set of mono-functionalized cis...
שמור ב:
| הוצא לאור ב: | Chem Sci |
|---|---|
| Main Authors: | , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Royal Society of Chemistry
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5409245/ https://ncbi.nlm.nih.gov/pubmed/28507680 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/c6sc03862j |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|